Dechra Relaunches Sedaxylan 20mg/ml Solution
24th January, 2023 11h52
Dechra is relaunching Sedaxylan 20 mg/ml solution for the sedation and premedication prior to general anaesthesia of dogs, cats, horses and cattle.
Sedaxylan 20 mg/ml contains the short acting alpha-2 agonist xylazine and is licensed for I/V administration. Providing flexible dosing options, it is also licensed for I/M administration in cattle and it is a popular premedication for use in cattle sedation and brief surgical procedures. It has zero milk withdrawal and short one day meat withdrawal and sedation occurs in cattle within two minutes I/V and five to 10 minutes I/M.
Sedaxylan 20 mg/ml joins Dechra’s Nerfasin vet 100 mg/ml solution in the company’s extensive anaesthesia and sedation range. Nerfasin vet also contains xylazine and is licensed for I/V administration for sedation and premedication prior to general anaesthesia in horses and cattle.
Alana McGlade, national sales manager at Dechra, comments: “Dechra offers a comprehensive range of anaesthesia and sedation products allowing vets to customise protocols to the individual animal. Sedaxylan 20mg/ml and Nerfasin vet 100 mg/ml solution provide vets with flexible and convenient dosing options.”
Both Sedaxylan 20 mg/ml and Nerfasin vet 100 mg/ml are available in 25ml vials.
For further information on Sedaxylan 20mg/ml or Nerfasin vet 100mg/ml, please contact your local Dechra territory sales manager or visit www.dechra.co.uk.
More from Dechra
- Dechra launches new PPID treatment, Pergocoat
- Dechra sponsors sessions at Virtual Veterinary Conference 2024
- Dechra launches new single-dose solution for BRD – Cyclofin
- Vet nurses ‘on cloud nine’ after winning £250 Virgin Experience Days gift cards at LVS
- Dechra launches hard-hitting Cushing’s campaign